Recursion Pharmaceuticals announced that it has received FDA clearance to begin clinical trials for REC-1245, an investigational drug targeting solid …
BioPharmCatalyst, a division of Scientist.com, has launched a new AI-powered chatbot named "Aiden" to deliver personalized customer service and support …
INBRAIN Neuroelectronics has announced the successful completion of the world’s first human procedure using their graphene-based brain-computer interface (BCI), a …
BioAge Labs (Richmond, CA), a clinical-stage biopharmaceutical company developing therapies for metabolic diseases such as obesity, has announced the pricing …
As healthcare systems embrace digital transformation, the increased reliance on connected devices, platforms, and remote work environments has significantly expanded …
Generate:Biomedicines has announced a multi-target collaboration with Novartis to develop protein therapeutics using its generative AI platform. The deal, valued …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.
